Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) (2020)

  • Cho, Jang Ho
  • Lim, Sung Hee
  • An, Ho Jung
  • Kim, Ki Hwan
  • Park, Keon Uk
  • 외 9명
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0
제목
Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) (2020)
저자
Cho, Jang HoLim, Sung HeeAn, Ho JungKim, Ki HwanPark, Keon UkKang, Eun JooChoi, Yoon HeeAhn, Mi SunLee, Myung HeeSun, Jong-MuLee, Se-HoonAhn, Jin SeokPark, KeunchilAhn, Myung-Ju
DOI
10.1200/JCO.20.00446
발행일
2020-04-10
유형
Correction
저널명
Journal of Clinical Oncology
38
11
페이지
1248 ~ 1248